Scrip's Five Must-Know Things - 26 May 2025

Audio roundup of selected biopharma industry content from Scrip over the business week ended 23 May 2025. In this episode: Novo Nordisk’s CEO forced out; quantifying biopharma’s contribution to the US economy; a history of MASH deals; lift for AstraZeneca’s asthma ambitions; and major Japanese firms see US revenue growth.  
https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-XJZXECGBDRDJLCM6FBOJSZNPK4/ 
 
This episode was produced with the help of AI text-to-voice and voice emulation tools. 
 
Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things